Therapy Area Industry Analysis

The cell therapy manufacturing market is segmented by manufacturing scale (preclinical, clinical, commercial), technology (viral vector, non-viral, cell processing, process development), therapy type, workflow, end user, and region. Forecast for 2026 to 2036.

June 05, 2026

Neurotrophins Market is segmented by Product (Nerve Growth Factor, Brain Derived Neurotrophic Factor, Neurotrophin 3, Dehydroepiandrosterone Sulfate), Application (Alzheimer's Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis, Others), End User (Hospitals, Diagnostic Centers, Others), and Region. Forecast for 2026 to 2036.

June 03, 2026

Unresectable Hepatocellular Carcinoma Market is segmented by Product (Chemotherapy, Molecularly Targeted Therapy, Immunotherapy), End User (Hospitals, Cancer Centers, Specialty Clinics), Cancer Indication (Lung Cancer, Breast Cancer, Colorectal Cancer), and Region. Forecast for 2026 to 2036.

June 03, 2026

The Rare Neurological Disease Treatment Market is segmented by Drug Class (Anti-depressants, Anticonvulsants, Immunomodulators, Nerve Protectors, Muscle Modulators), Indication (ALS, SMA, DMD, Rare Epilepsies, NPC, MLD), Route of Administration, Therapy Type, Distribution Channel, Patient Type, and Region. Forecast for 2026 to 2036.

June 02, 2026

The Hypersensitivity Pneumonitis Market market analysis report with forecast for 2026 to 2036.

May 30, 2026

Prophylactic HIV Drugs Market is segmented by Product (Pre Exposure Prophylaxis, Post Exposure Prophylaxis, Combination Prophylactic Regimens), Drug Class (Nucleoside Reverse Transcriptase Inhibitors, Integrase Strand Transfer Inhibitors, Entry And Fusion Inhibitors), Application (Pre Exposure Prophylaxis, Post Exposure Prophylaxis, Maternal Prophylaxis), and Region. Forecast for 2026 to 2036.

May 29, 2026

Obesity Management Market is segmented by Drug Class (GLP-1 Receptor Agonists, Dual GIP/GLP-1 Receptor Agonists, Lipase Inhibitors, Phentermine-topiramate, Bupropion-naltrexone), Treatment Type (Pharmacotherapy, Bariatric Procedure-supported Care, Structured Clinical Weight Management), Route of Administration (Injectable, Oral), Distribution Channel, End User, and Region. Forecast for 2026 to 2036.

May 29, 2026

Meningococcal Meningitis Treatment Market is segmented by Causative Micro-Organism (Bacterial, Viral, Fungal), Treatment Type (Antibiotic Therapy), Administration (Injectable, Oral), and Region. Forecast for 2026 to 2036.

May 27, 2026

Analgesics Market is segmented by Material (Polyethylene, Polyvinyl Chloride, Polystyrene, Polypropylene, Polyethylene Terephthalate, Others), Product Type (Bottles, Vials and Ampoules, Blisters, Bags, Pouches and Sachets, Prefilled Inhalers, Syringes and Cartridges, Containers and Jars, Caps and Closures, Trays, Medication Tubes), Application (Pharmaceuticals, Medical Devices), and Region. Forecast for 2026 to 2036.

May 27, 2026

Kyphoscoliosis Treatment Market is segmented by Condition Type (Scheuermann’s Kyphosis, Postural Kyphosis, Congenital Kyphosis), Treatment Type (Surgery, Bracing, Medications), End User (Hospitals, Clinics, Ambulatory Surgical Centres), and Region. Forecast for 2026 to 2036.

May 27, 2026

Gastroesophageal Junction Adenocarcinoma Therapeutics Market is segmented by Drug (Trastuzumab, Ramucirumab), Diagnosis (Endoscopy, CT Scan, PET Scan, X-ray), Treatment Type (Chemotherapy, Targeted Therapy, Esophagectomy Surgery, Esophageal Dilation), and Region. Forecast for 2026 to 2036.

May 27, 2026

Chronic Pulmonary Hypertension Treatment Market is segmented by Drug Type (Endothelin Receptor Antagonists, PDE-5 Inhibitors, Prostacyclin Analogs, sGC Stimulators), Route of Administration (Oral, Intravenous/Subcutaneous, Inhalational), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

May 27, 2026

Chronic Brain Damage Management Market is segmented by Diagnosis (Imaging Studies, Blood Tests, Brain Evaluations), Treatment Type (Physical Therapy, Occupational Therapy, Speech or Language Therapy, Psychotherapy), End User (Hospitals, Neurology Clinics, Independent Pharmacies), and Region. Forecast for 2026 to 2036.

May 27, 2026

Birch Allergy Treatment Market is segmented by Drug Class (Antihistamines, Cetirizine, Diphenhydramine, Decongestants, Pseudoephedrine, Oxymetazoline), Route of Administration (Oral, Intranasal), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), and Region. Forecast for 2026 to 2036.

May 27, 2026

Cancer Vaccines Market is segmented by Technology (Recombinant Cancer Vaccines, Whole-Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines), Treatment Method (Therapeutic Vaccines, Preventive Vaccines), Application (Prostate Cancer, Cervical Cancer, Other Applications), and Region. Forecast for 2026 to 2036.

May 27, 2026

Chiari Malformation Treatment Market is segmented by Clinical Classification (Type 1, Type 2, Type 3, Type 4), Treatment Type (Surgical Treatment, Medical Treatment), Diagnosis (MRI, Cine MRI, CT Scan, X-rays), and Region. Forecast for 2026 to 2036.

May 27, 2026

Pediatric Obesity Management Market is segmented by Drug Class (Liraglutide, Phentermine, Setmelanotide, Lorcaserin, Others), Route of Administration (Injectable, Oral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

May 27, 2026

Carcinoid Tumor Syndrome Management Market is segmented by Organ Affected (Small Intestine, Lungs, Liver, Rectum, Appendix, Stomach, Others), Therapy Type (Biological Therapy, Chemotherapy, Radiotherapy), Drug (Octreotide, Lanreotide, Telotristat Etiprate), and Region. Forecast for 2026 to 2036.

May 27, 2026

Severe Asthma Treatment Market is segmented by Drug Class (Anti-Inflammatory Drugs, Benralizumab, Reslizumab), Route of Administration (Inhaled, Subcutaneous, Intravenous, Oral), Device Type (Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Soft Mist Inhalers), and Region. Forecast for 2026 to 2036.

May 27, 2026

Cocaine Intoxication Treatment Market is segmented by Drug Class (Benzodiazepines, Alpha-Adrenergic Blockers, Calcium Channel Blockers, Opioid Analgesics (Controlled Use)), Route of Administration (Intravenous, Oral, Nasal, Inhalation), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region. Forecast for 2026 to 2036.

May 26, 2026

WHIM Syndrome Management Market is segmented by Drug Class (Mavorixafor, Plerixafor), Route of Administration (Oral, Injectable, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region. Forecast for 2026 to 2036.

May 26, 2026

Atypical Hemolytic Uremic Syndrome (aHUS) Treatment Market is segmented by Product Type (Monotherapy, Combination Therapy, Mono/Combination Therapy), Molecule Type (Monoclonal Antibodies, Small Molecules, Peptides, Gene Therapy, Polymers), Route of Administration (Intravenous, Subcutaneous, Oral, Parenteral, Topical), and Region. Forecast for 2026 to 2036.

May 26, 2026

Brain Tumor Drugs Market is segmented by Drug Class (Temozolomide, Bevacizumab, Carmustine, Cisplatin, Gefitinib, Erlotinib), Therapy (Chemotherapy, Targeted Therapy, Immunotherapy), Indication (Glioblastoma, Meningioma, Pituitary Tumor), and Region. Forecast for 2026 to 2036.

May 26, 2026

Generalized Anxiety Disorder Treatment Market is segmented by Drug Class (Antidepressants, Benzodiazepines, Buspirone), Therapy Type (Cognitive Behaviour Therapy (CBT), Behavioural Therapy, Interpersonal Therapy, Mindfulness-Based Cognitive Therapy), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region. Forecast for 2026 to 2036.

May 26, 2026

Gene Therapy in CNS Disorder Market is segmented by Gene Type (In Vivo Gene Therapy, Ex Vivo Gene Therapy), Indication (Alzheimer's Disease, Parkinson’s Disease, Huntington’s Disease, Batten Disease), Delivery Method (Viral Vectors, Non-Viral Methods, Direct Injection), and Region. Forecast for 2026 to 2036.

May 26, 2026

Castration-Resistant Prostate Cancer (CRPC) Treatment Market is segmented by Therapy Type (Hormonal Therapy, Chemotherapy, Immunotherapy, Radiotherapy), Drug Class (Non-Steroidal Antiandrogens, Antineoplastic Agents, Microtubule Inhibitors, Corticosteroids), Disease Stage (Metastatic CRPC, Non-Metastatic CRPC), and Region. Forecast for 2026 to 2036.

May 26, 2026

Advanced Cancer Pain Management Market is segmented by Drug Class (Monoclonal Antibody, Cannabinoid, Aminoindane), Route of Administration (Intravenous, Oral, Inhalational), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

May 25, 2026

Proton Pump Inhibitors Market is segmented by Drug Type (Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole, Dexlansoprazole), Route of Administration (Oral, Injectable), Dosage Form (Tablet, Capsules, Injection, Others), and Region. Forecast for 2026 to 2036.

May 25, 2026

Leukemia Therapeutics Treatment Market is segmented by Treatment (Targeted Drugs & Immunotherapy, Chemotherapy), Mode of Administration (Single Molecule, Oral), Indication (AML, CML, ALL, CLL), and Region. Forecast for 2026 to 2036.

May 25, 2026

The Hormone Replacement Therapy Market is segmented by Therapy Area (Estrogen Replacement Therapy; Testosterone Replacement Therapy; Progestogen Hormone Therapy; Thyroid Hormone Replacement Therapy; Growth Hormone Replacement Therapy), Dosage Form (Oral Tablets and Capsules; Injectables; Gels and Creams; Implants; Patches), Indication, End Use Sector, Administration Route, and Region. Forecast for 2026 to 2036.

May 25, 2026

Unstable Angina Therapeutics Market is segmented by Treatment (Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Graft Surgery, Drug Class, Supplemental Oxygen Therapy), End-Use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), Drug Class (Antiplatelet Agents, Anticoagulants, Beta Blockers, Nitrates, Statins), and Region. Forecast for 2026 to 2036.

May 23, 2026

Urinary Retention Therapeutics Market is segmented by Drug Class (Anticholinergic and Antispasmodic Agents, Skeletal Muscle Relaxants, Antidepressants, Alpha Blockers, Topical Estrogens), Incontinence Type (Stress Incontinence, Urge Incontinence, Overflow Incontinence, Mixed Incontinence), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

May 23, 2026

Autosomal Dominant Polycystic Kidney Disease Treatment Market is segmented by Treatment Type (Kidney Failure Treatment, Pain and Inflammation Treatment, Urinary Tract Infection Treatment, Kidney Stone Treatment), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Drug Class (Vasopressin V2 Receptor Antagonists, Renin Angiotensin System Inhibitors, Analgesics, Antibiotics), and Region. Forecast for 2026 to 2036.

May 23, 2026

Retinal Vein Occlusion Treatment Market is segmented by Drug Class (Ranibizumab, Aflibercept, Bevacizumab, Dexamethasone), Type (Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion), Diagnosis (Optical Coherence Tomography, Fundoscopic Examination, Fluorescein Angiography), and Region. Forecast for 2026 to 2036.

May 23, 2026

The Radiation Toxicity Radiation Sickness Acute Radiation Syndrome Market is segmented by Component (Active Pharmaceutical Ingredients, Hematopoietic Growth Factors, Radioprotective Molecules, Anti-infective APIs, Excipients and Stabilizers, Biological Components), Manufacturing Technique, Technology, Packaging, Solution, End-Use Industry, and Region. Forecast for 2026 to 2036.

May 23, 2026

Portal Hypertension Management Market is segmented by Treatment (Drug Class, Liver Transplantation, Endoscopic Therapy, Shunting Procedures), Application (Variceal Bleeding, Ascites Management, Hepatic Encephalopathy), End Use (Hospitals, Specialty Clinics, Ambulatory Care Centers), and Region. Forecast for 2026 to 2036.

May 22, 2026

Precocious Puberty Treatment Market is segmented by Drug Class (Leuprorelin, Histrelin, Triptorelin, Nafarelin), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Route Of Administration (Injectable, Implant, Nasal), and Region. Forecast for 2026 to 2036.

May 22, 2026

Radiation-Induced Fibrosis Treatment Market is segmented by Product (Pharmaceuticals, Corticosteroids, NSAIDs, Vitamin Based Therapy, Combination Drug Therapy), Therapy Type (Hyperbaric Oxygen Therapy, Physiotherapy, Microcurrent Stimulation, Immunotherapy), Route of Administration (Oral, Injectable, Topical), and Region. Forecast for 2026 to 2036.

May 22, 2026

Infertility Drugs Market is segmented by Drug Class (Gonadotrophins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators SERMs, Biguanides, Other Drug Classes), End User (Female, Male), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), and Region. Forecast for 2026 to 2036.

May 22, 2026

Methotrexate Drug Market is segmented by Indication (Psoriasis, Rheumatoid Arthritis, Cancer, Other Indications), Manufacturing Mode (In-house Manufacturing, Contract Manufacturing), Synthesis Type (Chemical Based API, Highly Potent API (HPAPI)), and Region. Forecast for 2026 to 2036.

May 21, 2026

Infertility Treatment Market is segmented by Product (Media & Consumables, Equipment, Accessories), Procedure (Assisted Reproductive Technology (ART), Artificial Insemination, Fertility Surgeries, Other Infertility Treatment Procedures), Patient Type (Female Infertility Treatment, Male Infertility Treatment), and Region. Forecast for 2026 to 2036.

May 20, 2026

Eosinophilic Esophagitis Market is segmented by Drug Class (Corticosteroids, Proton Pump Inhibitor (PPI), Late-Stage Pipeline Drugs), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

May 20, 2026

The acute kidney injury treatment market is segmented by Treatment Type (Dialysis, Drug Therapy, Supportive Care), Injury Type (Pre-Renal Injury, Intrinsic Renal Injury, Post-Renal Injury), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Healthcare, Others), and Region (North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, Middle East and Africa). Forecast for 2026 to 2036.

May 19, 2026

The PARP Inhibitor Market is Segmented by Drug Type, Indication, Distribution Channel, Mechanism of Action, End User, and Region. Forecast for 2026 to 2036.

May 19, 2026

Scleroderma Treatment Market is segmented by Drug Class (Anti-Inflammatory Scleroderma Treatment Agents, Immunosuppressive Scleroderma Treatment Agents, Vascular Scleroderma Treatment Agents, Anti-Fibrotic Scleroderma Treatment Agents, Other Scleroderma Treatment Drugs), Type (Systemic Scleroderma Treatment, Localized Scleroderma Treatment), Distribution Channel (Institutional Sales Of Scleroderma Treatment Drugs, Retail Sales Of Scleroderma Treatment Drugs, Online Sales Of Scleroderma Treatment Drugs), and Region. Forecast for 2026 to 2036.

May 19, 2026

Inherited Retinal Diseases Treatment Market is segmented by Treatment Type (Gene therapy treatment, Symptomatic treatment), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Region. Forecast for 2026 to 2036.

May 19, 2026

Fabry Disease Market is segmented by Treatment (Enzyme replacement therapy, Gene therapy, Pharmaceutical formulations containing agalsidase alpha, Analgesics, Anticonvulsants, NSAIDs), End User Type (Hospitals, Clinics), and Region. Forecast for 2026 to 2036.

May 18, 2026

Schizophrenia Treatment Market is segmented by Product Type (Atypical antipsychotic drugs, Conventional or typical antipsychotic drugs, Therapies), Distribution Channel (Clinics, Hospitals including hospital pharmacies, Retail pharmacies, Rehabilitation Centers), and Region. Forecast for 2026 to 2036.

May 18, 2026

Eye Infections Treatment Market is segmented by Drug Class (Antibiotics, Antivirals, Antifungals, Antihistamines, Corticosteroids, Glucocorticoids), Indications (Conjunctivitis, Keratitis, Endophthalmitis, Blepharitis, Stye or sty, Uveitis, Cellulitis, Ocular herpes), Dosage Form (Tablet, Capsule, Ophthalmic ointment, Eye drops, Others), and Region. Forecast for 2026 to 2036.

May 18, 2026

Inherited Orphan Blood Disorders Therapeutics Market is segmented by Disorder Type (Sickle Cell Anemia, Thalassemia, Hereditary Angioedema (HAE)), Therapy Type (Blood Transfusion, Bone Marrow Transplant, Antibiotics, Analgesics, Hydroxyurea, Iron Chelation, Folic Acid, C1-Inhibitors, Kallikrein Inhibitor, Others), End User (Hospitals, Pharmacies, Drug Stores), and Region. Forecast for 2026 to 2036.

May 18, 2026

Microsclerotherapy Treatment Market is segmented by Product (Sclerosant Type, Needles, Others), End User (Hospitals, Aesthetic Treatment Clinics, Others), and Region. Forecast for 2026 to 2036.

May 18, 2026

Inflammatory Diseases Market is segmented by Diseases (Asthma, Chronic Obstructive Pulmonary Disease, Heart Disease, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Disease, Bone Disease, Rheumatoid Arthritis, Osteoarthritis, Others, Respiratory Diseases), Drug Class (Anti-Inflammatory Biologics, Non-Steroidal Anti-Inflammatory Drugs, Corticosteroids, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Pharmacy), and Region. Forecast for 2026 to 2036.

May 18, 2026

Injectable Anti-Wrinkle Treatment Market is segmented by Type (Muscle Relaxants, Botox Injections, Hyaluronic Acid Wrinkle Filler, Belotero Balance, Juvederm, Perlane, Restylane, Synthetic Wrinkle Fillers, Radiesse, Sculptra, Silicone, Collagen Wrinkle Fillers, ArteFill, Cosmoderm, Evolence, Fibrel, Others, Autologous Wrinkle Fillers), Skin Condition Treated (Forehead Lines, Frown Lines (Between The Eyes), Crow’s Feet (Around The Eyes), Bunny Lines (Sides Of Nose), Upper Lip Lines (Smoker’s Lines), Sagging Eyebrows, Dimpled Chin, Hyperhidrosis (Excessive Sweating)), and Region. Forecast for 2026 to 2036.

May 18, 2026

The acetaminophen market is segmented by Product Type (Acetaminophen / Acetaminophen with Opioids / Others), Administration Mode (Oral / Injectable / Others), Sales Type (OTC / Rx) and Distribution Channel (Hospital Pharmacies / Retail Pharmacies / Drug Stores / E-commerce / Others). Forecast for 2026 to 2036.

May 18, 2026

The Vaccines Market is Segmented by Vaccine Type (Inactivated, Live Attenuated, Recombinant, Toxoid, and Subunit & Conjugate), Valance (Monovalent and Multivalent), Route of Administration (Injectable and Oral), Indication (Influenza, Pneumococcal Diseases, Human Papillomavirus, Meningococcal Diseases, Rotavirus, MMR, Hepatitis, DTP, and Polio), and Distribution Channel (Hospital Pharmacies, Institutional Sales, and Retail Pharmacies). Forecast for 2025 to 2035.

May 18, 2026

The opioid analgesics market is segmented by Product (Morphine, Codeine, Fentanyl, Meperidine, Methadone, Tramadol, Oxycodone, Dextromethorphan, Buprenorphine, Others), Indication (Surgical Pain, Cancer Pain, Neuropathic Pain, Others), Route of Administration (Oral, Parenteral, Transdermal, Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies). Forecast for 2025 to 2035.

May 18, 2026

The Ophthalmic Eye Drops Market is segmented by Product (Dilation Drops, Glaucoma Drops, Steroid Drops, Antibiotic Drops, Anesthetic Drops, Other Products), Indication (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Retinal Disorders, Uveitis, Other Indications), Drug Formulation (With Preservative, Preservative Free), Container Type (Multiple-Dose Container, Single Dose Container), Distribution Channels (Institutional Sales, Retail Sales), and Retail Outlet (Retail Pharmacies, Drug Stores, Mail Order Pharmacies). Forecast for 2026 to 2036.

May 16, 2026

GLP-1 Receptor Agonist Market The GLP-1 receptor agonist market is segmented by Drug (Semaglutide, Exenatide, Lixisenatide, Liraglutide, Dulaglutide, and Others), by Route of Administration (Oral and Parenteral), by Indication (Diabetes, Obesity, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region. Forecast for 2026 to 2036.

May 15, 2026

Bullous Keratopathy Market is segmented by By Therapies (Emmecell, Cellusion), End User (Hospitals, Surgical Centers), Medical Management (Lubricants, Steroids, Hyperosmotic agents, Anti- Glaucoma drugs, Antibiotics), and Region. Forecast for 2026 to 2036.

May 15, 2026

Sennosides Market The Sennosides Market is Segmented by Drug Type (Sennosides and Mixed), Dosage Type (Tablet, Chewables, Film-Coated, Liquid, and Powders), Application, Distribution Channel, and Region. Forecast for 2025 to 2035.

May 15, 2026

Blepharitis Treatment Market is segmented by Treatment Type (Artificial Tears, Eye Cleansers, Antibiotic Therapy, Topical Antibiotic Therapy, Oral Antibiotic Therapy), Distribution Channel (E-Commerce, Drug Store, Hypermarkets And Supermarkets, Pharmacies), and Region. Forecast for 2026 to 2036.

May 14, 2026

Papillary Thyroid Cancer Market is segmented by Treatment (Surgery, Iodine Therapy, Thyroxin Treatment, External Radiotherapy, Chemotherapy, Cisplatin, Doxorubicin, Drugs, Levothyroxine, Radioiodine), End User (Hospital, Oncology Centres, Hospital Pharmacies, Retail Pharmacies), and Region. Forecast for 2026 to 2036.

May 14, 2026

Botulism Market is segmented by Drug Type (Heptavalent Botulinium Antitoxin, Antitoxin, Trivalent Antitoxin, Antibiotics), Distribution Channel (Hospitals including hospital pharmacies, Clinics, Retail pharmacies), and Region. Forecast for 2026 to 2036.

May 13, 2026

Traumatic Brain Injuries Treatment Market is segmented by Treatment Type (Drugs, Analgesics, Anti-Anxiety Agents, Anti-Coagulants, Anti-Convulsants, Anti-Depressants, Anti-Psychotics, Others, Surgery), Route Of Administration (Oral, Injectable), Distribution Channel (Hospital Pharmacies, Drug Stores, Independent Pharmacies), and Region. Forecast for 2026 to 2036.

May 13, 2026

Peptide Therapeutics Market is segmented by Application (Cancer, Cardiovascular Diseases, Central Nervous System Disorders, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications), Route of Administration (Parenteral Route of Administration, Mucosal Route of Administration, Oral Route of Administration, Transdermal Route of Administration), Drug Type (Branded Drugs, Generic/Biosimilar Drugs), and Region. Forecast for 2026 to 2036.

May 13, 2026

Bronchitis Treatment Market is segmented by Type (Acute Bronchitis, Chronic Bronchitis), Treatment (Drugs, Oxygen Therapy), Drug Class (Antibiotics, Anti-inflammatory Drugs, Bronchodilator, Others), and Region. Forecast for 2026 to 2036.

May 13, 2026

Tuberculosis Therapeutics Market is segmented by Disease Type (Active TB, Latent TB), Treatment Type (First-Line of Drugs, Second-Line of Drugs, Others), Diagnosis (Blood Tests, Imaging Tests, Sputum Tests, Others), and Region. Forecast for 2026 to 2036.

May 12, 2026

Systemic Lupus Erythematosus SLE Drugs Market is segmented by Drug Class (Immunosuppresants, NSAIDs, Corticosteroids, Antimalarials, Biologics), Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), Route of Administration (Oral, Intravenous , Subcutaneous), and Region. Forecast for 2026 to 2036.

May 12, 2026

The Lung Cancer Therapeutics Market is segmented by Drug Class (Cytotoxic Chemotherapy Drugs, Targeted Therapies, Angiogenesis Inhibitors), Formulation (Injectable, Oral), Molecule Type (Small Molecule, Large Molecule), Cancer Type (Non Small Cell Lung Cancer, Small Cell Lung Cancer), Distribution Channel (Institutional Sales, Retail Sales), and Region. Forecast for 2026 to 2036.

May 11, 2026

Vascular Ulcer Treatment Market is segmented by Ulcer Type (Arterial Ulcers, Neurotrophic Ulcers, Venous Ulcers, Diabetic Ulcers), Treatment (Compression, Gradual Compression, Intermittent Pneumatic Compression, Drugs, Antibiotics, Pentoxifylline, Topical Steroids, Aspirin, Dressings, Surgical Therapy, Skin Grafting), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies & E-Commerce, Drugstores), and Region. Forecast for 2026 to 2036.

May 08, 2026

Oncology Adjuvants Market is segmented by Adjuvants (Chemotherapy-Based Adjuvants, Targeted Therapy Adjuvants, Immunotherapy Adjuvants, Hormonal (Endocrine) Adjuvants, Combination Therapy Adjuvants), Route of Administration (Oral adjuvant Therapies, Intravenous (IV infusion), Subcutaneous or Injectable, Radiopharmaceutical Adjuvants, Others), Indication (Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Gastric cancer, Ovarian cancer, Pancreatic cancer, Melanoma, Leukemia, Lymphoma, Multiple myeloma), and Region. Forecast for 2026 to 2036.

May 07, 2026

Lung Disease Therapeutics Market is segmented by Disease Type (COPD, Chronic Bronchitis, Emphysema, Bronchopulmonary Dysplasia, Pulmonary Fibrosis, Asthma, Other Lung Disease Therapeutics), Treatment Type (Drugs, Bronchodilators, Antibiotics, Anti-inflammatory Agents, Oxygen Therapy, Other Treatment Types), End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and E-commerce, Drugstores, Other Distribution Channels), and Region. Forecast for 2026 to 2036.

May 07, 2026

Thromboprophylactic Drugs Market is segmented by Drug Class (Direct oral anticoagulants (DOACs), Low molecular weight heparins (LMWHs), Vitamin k antagonists (VKAs), Factor Xa inhibitors, Anticoagulants, Antiplatelet agents), Application (Venous thromboembolism (VTE), Atrial fibrillation (AF) and stroke prevention, Post-surgical prophylaxis, Cancer-associated thrombosis (CAT), Pregnancy-associated thrombosis, Thromboprophylaxis in cardiovascular diseases, Others), End User (Hospitals, Ambulatory surgical centers (ASCs), Clinics, Home care settings, Specialty pharmacies), and Region. Forecast for 2026 to 2036.

May 06, 2026

General Anesthesia Drugs Market is segmented by Drug Class (Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam), Route of Administration (Intravenous Anesthesia, Inhaled Anesthesia), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), and Region. Forecast for 2026 to 2036.

May 06, 2026

The Malaria Treatment Market is segmented by Drug Type (ACTs, Quinine, Antifolates, Atovaquone, Others); Route of Administration (Oral, Injectable); Distribution Channel (Public Sales, Private Sales); Product Type (Generic, Branded); Patient Group (Children, Adults, Infants), and Region. Forecast for 2026 to 2036.

May 04, 2026

Heterozygous Familial Hypercholesterolemia (HEFH) Management Market is segmented by Product Type (Gemcabene Calcium, MGL-3196, ST-103, Others), Application (Hospitals, Medical Centers, Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

May 04, 2026

Congenital Hyperinsulinism Treatment Market is segmented by Treatment Method (Drug Therapy, Surgery), Application (Hospitals, Clinics, Others), End Use (Hospitals, Specialty Clinics, Home Care Settings), and Region. Forecast for 2026 to 2036.

May 02, 2026

Intestinal Fistula Treatment Market is segmented by Drug Class (Anticholinergic, Proton-Pump Inhibitors, H2 Blockers, Antidiarrheals), Route of Administration (Oral, Parenteral, Rectal, Transdermal, Intravenous), Distribution Channel (Hospital Pharmacies, Clinical Pharmacies, Drug Stores, Online Pharmacies), and Region. Forecast for 2026 to 2036.

April 30, 2026

Rheumatic-Heart Disease Management Market is segmented by Product Category (Valve, Myocarditis, Pericarditis), Application (Hospital, Diagnostic Centre, Research Centre), Technology (Minimally Invasive Surgery, Open Heart Surgery, Telemedicine Monitoring), and Region. Forecast for 2026 to 2036.

April 30, 2026

Chronic Smell and Flavor Loss Treatment Market is segmented by Classification (Smell Disorder, Taste disorder), Symptoms (Anosmia or Hyposmia, Dysgeusia, Ageusia), Taste Type (Psychophysical Assessment Test, Self-Assessment Test, Imaging Test, Other Tests), and Region. Forecast for 2026 to 2036.

April 30, 2026

The Corneal Ulcer Treatment Market is segmented by Ulcer Type (Bacterial Ulcers, Fungal Ulcers, Viral Ulcers, Acanthamoeba Ulcers, Neurotrophic Ulcers, Sterile Ulcers), Treatment Type (Drug Therapy, Biologic Therapy, Supportive Therapy, Compounded Therapy, Adjunct Procedures), Drug Class (Antibiotics, Antifungals, Antivirals, Antiparasitics, Nerve Growth Factor, Artificial Tears), Dosage Form (Eye Drops, Gels, Ointments, Suspension, Biologic Solution), End User (Hospitals, Ophthalmology Clinics, Ambulatory Centers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

April 30, 2026

Takotsubo Syndrome Therapeutics Market is segmented by Diagnosis (Echocardiography, EKG, Cardiac MRI, Myocardial Infarction, Apical Hypertrophic Cardiomyopathy, Others), Application (Hospitals, Ambulatory Surgical Centres), Product (Beta Blockers, ACE Inhibitors, Angiotensin Receptor Blockers, Calcium Channel Blockers, Diuretics, Anticoagulants), and Region. Forecast for 2026 to 2036.

April 30, 2026

Hutchinson-Gilford Progeria Syndrome Market is segmented by Treatment (Farnesyltransferase Inhibitor (FTI), MRI scan, Hearing tests, Cardiovascular, Others), End User (Hospitals & Surgical Centres, Specialty Clinics, Others), Application (Pediatric Patients, Geriatric Research, Rare Disease Programs), and Region. Forecast for 2026 to 2036.

April 30, 2026

Hyperammonemia Treatment Market is segmented by Treatment Type (Sodium Phenylbutyrate, Amino Acid Supplements, Glycerol Phenylbutyrate, Sodium Benzoate, Others), Route of Administration (Oral, Injectable), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

April 30, 2026

Cryotherapy Market is segmented by Device Type (Cryo Probes, Cryogen, Gas Cylinders, Localized Devices, Cryochambers and Cryosaunas, Other Device Types), Therapy Type (Cryosurgery, Icepack Therapy, Chamber Therapy, Cryo Monitoring/Inventory Management), Application (Surgical Application, Pain Management, Other Applications), and Region. Forecast for 2026 to 2036.

April 30, 2026

Prinzmetal Angina Therapeutics Market is segmented by Drug Class (Beta Blockers, Calcium Antagonists, Anti-coagulants, Anti-Platelets, Anti-Anginal, ACE Inhibitors, Nitrates), Disease Type (Stable or Chronic Angina, Unstable Angina, Variant and Microvascular Angina), Application (Acute Prinzmetal Angina, Chronic Prinzmetal Angina, Preventive Therapy), and Region. Forecast for 2026 to 2036.

April 30, 2026

Restrictive Cardiomyopathy Treatment Market is segmented by Type (Restrictive Cardiomyopathy, Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy, Unclassified Cardiomyopathy), Treatment (Anticoagulants, Antiarrhythmics, Anti-Hypertensives, Cardiac Glycosides, Diuretics), End User (Hospitals and Clinics, Homecare, Others), and Region. Forecast for 2026 to 2036.

April 30, 2026

Andersen-Tawil Syndrome Treatment Market is segmented by Disease Type (Type 2, Type 1), Drug Class (Beta-Blockers, Carbonic Anhydrate Inhibitors, Acetazolamide, Dichloropenamide, Antiarrhythmic Drugs, Amiodarone, Flecainide, Atenolol), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region. Forecast for 2026 to 2036.

April 30, 2026

Pituitary Stalk Interruption Syndrome Treatment Market is segmented by Treatment (Hormone Replacement, MRI Scan, Others), Symptoms (Hypoglycemia, Jaundice, Micropenis, Cryptorchidism, Others), End Users (Hospitals & Surgical Centers, Specialty Clinics, Research Institutes), and Region. Forecast for 2026 to 2036.

April 30, 2026

Hyperglycemia Treatment Market is segmented by Treatment (Insulin Therapy, Fluid Replacement, Electrolyte Replacement, Other Treatments), Mode of Administration (Oral, Topical), Product (Insulin, Oral Antidiabetic Drugs, GLP 1 Receptor Agonists, SGLT 2 Inhibitors, DPP 4 Inhibitors), and Region. Forecast for 2026 to 2036.

April 30, 2026

Laband Syndrome Therapeutics Market is segmented by Drug Class (NSAIDS, Bisphosphonate, Skeletal Muscle Relaxant), Route of Administration (Oral, Rectal, Parental, Topical), Distribution Channel (Hospital Pharmacies, Clinical Pharmacies, Drug Stores, Online Pharmacies), and Region. Forecast for 2026 to 2036.

April 29, 2026

Heparin-Induced Thrombocytopenia (HIT) Treatment Market is segmented by Drug Types (Argatroban, Danaparoid, Lepirudin), Test Types (Enzyme-linked immunosorbent assay (ELISA), Enzyme immunoassay (EIA), Serotonin release assay (SRA)), End User (Hospitals, Diagnostic centers, Specialized clinics), and Region. Forecast for 2026 to 2036.

April 29, 2026

Hematopoietic Stem Cell Transplantation Market is segmented by Transplant Type (Allogeneic, Autologous), Indication (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, Other Non-Malignant Disorders), Application (Peripheral Blood Stem Cells Transplant, Bone Marrow Transplant, Cord Blood Transplant), and Region. Forecast for 2026 to 2036.

April 29, 2026

Ringworm Treatment Market is segmented by Drug Class (Antifungals, Steroids, Anti-infective, Others), Route of Administration (Topical, Oral), Infection Type (Tinea Corporis, Tinea Pedis, Tinea Cruris, Tinea Capitis, Tinea Manuum), and Region. Forecast for 2026 to 2036.

April 29, 2026

Fucosidosis Therapeutics Market is segmented by Therapy (Bone Marrow Transplantation, Antibiotic Therapy, Fluid Replacement Therapy), End-User (Hospital, Homecare, Specialty Clinics, Others), Route Of Administration (Intravenous, Intrathecal, Oral, Inhalation), and Region. Forecast for 2026 to 2036.

April 29, 2026

Filariasis Treatment Market is segmented by Drug Type (Drugs, Vaccine), Application (Hospitals, Clinics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Distribution Programs), and Region. Forecast for 2026 to 2036.

April 29, 2026

Drug Eruptions Treatment Market is segmented by Drug Class (Corticosteroids, Immunosuppressant Drugs, Anti-cytokines, Hemorrheologic Agents, Antihistamines), Route of Administration (Oral, Parenteral, Intravenous, Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Others), and Region. Forecast for 2026 to 2036.

April 29, 2026

Anorectal Malformation Treatment Market is segmented by Treatment Type (Anorectal Repair, Colostomy, Colostomy Closure), End User (Hospitals, Specialty Clinics), Route of Administration (Oral, Parenteral, Topical, Rectal), and Region. Forecast for 2026 to 2036.

April 28, 2026

Eosinophilic Granulomatosis with Polyangiitis (EGPA) Treatment Market is segmented by Drug Class (Biologics, Steroids, Immunosuppressant, Immune Globulins), Route of Administration (Intravenous, Oral, Intramuscular), Distribution Channel (Hospital Pharmacies, Drug stores, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

April 28, 2026

Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Treatment Market is segmented by Drug Type (Anti-Fibrotic Medication, Corticosteroids, Immune Suppressing, Others), Route of Administration (Oral, Injectable), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

April 28, 2026

Coxsackievirus Infections Treatment Market is segmented by Drug Type (Anti-inflammatory, Acetaminophen, Ibuprofen, Nucleoside Analogue Antivirals, Others), Route of Administration (Oral, Topical, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

April 28, 2026

Donohue Syndrome Treatment Market is segmented by Treatment (IGF-1 Therapy, Insulin Pump Therapy), End User (Hospitals, Clinics, Others), Drug Class (Insulin Like Growth Factor, Insulin Analog, Hormonal Therapy, Metabolic Regulators), and Region. Forecast for 2026 to 2036.

April 28, 2026

Alcohol Use Disorder Treatment Market is segmented by Disorder Type (Alcohol Dependence, Alcohol Abuse, Alcohol Addiction, Alcoholism), Treatment Type (Medication, Therapy, Multidisciplinary Treatment), Drug Class (Naltrexone, Acamprosate, Disulfiram, Nalmefene), and Region. Forecast for 2026 to 2036.

April 28, 2026

Pork Tapeworm Infection Treatment Market is segmented by Drug Type (Praziquantel, Albendazole, Nitazoxanide, Others), Treatment (CT Scan, MRI, Ultrasound, X-Ray), End User (Hospitals & Laboratories, Specialty Clinics, Ambulatory Surgical Centres, Others), and Region. Forecast for 2026 to 2036.

April 28, 2026

Dengue Fever Treatment Market is segmented by Type (Vaccines, Drug), Route of Adminstration (Parenteral, Oral), End-User (Hospital, Homecare, Specialty Clinics, Others), and Region. Forecast for 2026 to 2036.

April 28, 2026

Marburg Virus Disease Therapeutics Market is segmented by Drug Classiication (Antibiotics, Antiemetic, Nitro-glycerine, Loperamide, Others), Route of Administration (Parenteral, Oral), End use (Hospitals, Specialty Clinics, Ambulatory Surgical Centres, Others), and Region. Forecast for 2026 to 2036.

April 28, 2026

Bartonellosis Therapeutics Market is segmented by Drug Class (Antibiotics, NSAIDs), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region. Forecast for 2026 to 2036.

April 28, 2026

Cytokine Release Syndrome Management Market is segmented by Cytokine Type (Interleukins (IL-2), Tumor Necrosis Factor (TNF), Interferons (IFN), Epidermal Growth Factor (EGF)), Therapeutic Application (Cancer, Asthma, Airway Inflammation, Arthritis, Others), End User (Hospitals, Specialty Clinics, Others), and Region. Forecast for 2026 to 2036.

April 28, 2026

Acrocallosal Syndrome Therapeutics Market is segmented by Category (Evolocumab, Losmapimod, Praluent), Syndromes (Non-ST Elevation Myocardial Infarction, ST Elevation Myocardial Infarction, Unstable Angina), Route of Administration (Injectable, Oral), and Region. Forecast for 2026 to 2036.

April 28, 2026

PD1 Non-Small Cell Lung Cancer Treatment Market is segmented by Drug Type (Pembrolizumab, Nivolumab, Atezolizumab, Avelumab, Durvalumab), Cancer Type (Adenocarcinoma, Squamous Cell carcinoma, Large-cell carcinoma), Treatment (Immunotherapy, Chemotherapy, Targeted therapy, Others), and Region. Forecast for 2026 to 2036.

April 28, 2026

Chronic Refractory Cough Treatment Market is segmented by Drug Class (Corticosteroids, Antibiotics, Decongestants, Antihistamines, Acid Blockers, Others), Route of Administration (Oral, Nasal, Parenteral, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

April 28, 2026

Diamond-Blackfan Anemia (DBA) Syndrome Therapeutics Market is segmented by Treatment (Corticosteroids, Chelation Therapy, Blood Transfusions, Stem Cell Transplant, Others), End User (Hospitals, Clinics, Others), Drug Class (Corticosteroids, Immunosuppressants, Chelating Agents, Biologics, Targeted Therapies), and Region. Forecast for 2026 to 2036.

April 28, 2026

Thrombocytopenia Treatment Market is segmented by Drug Class (Glucocorticoids, Lysosomal Enzyme, Platelet Stimulating Agent), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Treatment (Pharmacological Treatment, Platelet Transfusion, Splenectomy, Supportive Care), and Region. Forecast for 2026 to 2036.

April 28, 2026

Chronic Granulomatous Disease (CGD) Management Market is segmented by Category (X-Linked Chronic Granulomatous Disease, Autosomal Recessive Chronic Granulomatous Disease), Diagnosis (Genetic Testing, Neutrophil Function Tests, Prenatal Testing), Treatment (Infection Management, Trimethoprim, Sulfamethoxazole, Itraconazole, Interferon-gamma, Stem Cell Transplantation, Others), and Region. Forecast for 2026 to 2036.

April 28, 2026

Central Pain Syndrome Management Market is segmented by Drug Class (Anticonvulsants, Antidepressants), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), and Region. Forecast for 2026 to 2036.

April 28, 2026

Aarskog-Scott Syndrome Treatment Market is segmented by Category (Facial, Limb, Genital, Others), Treatment (Growth Hormone Therapy, Inguinal Hernia Repair Surgery, Cryptorchidism Surgery, Cleft Lip or Palate Surgery, Strabismus Treatment, Nystagmus Treatment, Auxiliary Treatment), End Use (Hospitals, Clinics, Ambulatory Surgical Centres, Others), and Region. Forecast for 2026 to 2036.

April 28, 2026

Large Granular Lymphocytic Leukemia (LGLL) Therapeutics Market is segmented by Drug Type (Methotrexate, Cyclophosphamide, Cyclosporine, Fludarabine, Alemtuzumab), Therapy (Chemotherapy, Radiation therapy, Stem cell transplants, Targeted therapy), Indication (Acute Myeloid leukemia, Acute lymphocytic leukemia, Chronic Myelogenous leukemia, Chronic Lymphocytic leukemia), and Region. Forecast for 2026 to 2036.

April 28, 2026

Edward’s Syndrome Treatment Market is segmented by Syndromes Types (Full Trisomy 18, Mosaic Trisomy 18, Partial Trisomy 18), Treatment (Cardiac Treatment, Assisted Feeding, Orthopaedic Treatment, Psychosocial Support), End User (Hospitals, Clinics, Ambulatory Surgical Centres), and Region. Forecast for 2026 to 2036.

April 28, 2026

Vaginal and Vulval Inflammatory Diseases Treatment Market is segmented by Indication (Vaginal Dryness, Vaginal Burning, Vaginal Discharge, Genital Itching, Recurrent Urinary Tract Infections, Urinary Incontinence, Others), Treatment (Corticosteroid Ointments, Anti-Itch Medications, Anti-Itch Emollients), End User (Specialty Clinics, Hospital Pharmacies, Others), and Region. Forecast for 2026 to 2036.

April 28, 2026

Idiopathic Pulmonary Fibrosis Management Market is segmented by Drug Class (Nintedanib, Pirfenidone, Interferon Gammato1b, Others), Treatment (Oxygen Therapy, Lung Transplant, Others), Route of Administration (Oral, Injectable), and Region. Forecast for 2026 to 2036.

April 28, 2026

Hidradenitis Suppurativa (HS) Treatment Market is segmented by Clinical Stages (Hurley Stage 2- Moderate, Hurley Stage 1- Low, Hurley Stage 3- High), Treatment Type (Biologics, Medication, Antibiotics, Hormonal Therapy, Immune Suppurativa Drugs, Zinc Supplements, Pain Medications, Surgery), Route of Administration (Oral, Tropical), and Region. Forecast for 2026 to 2036.

April 28, 2026

Complicated Urinary Tract Infections Treatment Market is segmented by Drug Class (Cephalosporin, Penicillin and Combinations, Quinolones, Azoles and Amphotericin B, Nitro Furans), Distribution Channel (Hospital Pharmacies, Gynecology and Urology Clinics, Drug Stores, Retail Pharmacies), Mechanism Of Action (Broad-Spectrum Antibiotics, Beta-Lactamase Inhibitor Combinations, Carbapenems, Aminoglycosides), and Region. Forecast for 2026 to 2036.

April 28, 2026

Transfusion Dependent Thalassaemia Management Market is segmented by Therapy (Iron Chelating Drugs, Erythroid Maturation Agents, Stem Cell Therapy, Others), End-User (Hospital, Homecare, Specialty Clinics, Others), Product Category (Drugs, Medical Devices, Biologics), and Region. Forecast for 2026 to 2036.

April 28, 2026

Chloangiocarcinoma (CCA) Therapeutics Market is segmented by Treatment Type (Targeted Therapy, Chemotherapy, Immunotherapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Mechanism Of Action (Biomarker Guided Therapies, Immune Checkpoint Modulation, Cytotoxic Agents), and Region. Forecast for 2026 to 2036.

April 28, 2026

Cell and Gene Therapy Manufacturing Market is segmented by Therapy Type (Gene Therapy Manufacturing, Cell Therapy Manufacturing, Stem Cell Therapy, Non-Stem Cell Therapy), Scale (Commercial Scale Manufacturing, Pre-commercial/ R&D Manufacturing), Mode (Contract Manufacturing, In-house Manufacturing), and Region. Forecast for 2026 to 2036.

April 28, 2026

Tuberculous Meningitis Treatment Market is segmented by Treatment (Antibiotic Therapy, Adjunctive Corticosteroid Therapy, Neurosurgical Management), End User (Hospitals, Specialty Clinics, Others), Route Of Administration (Oral, Injectable), and Region. Forecast for 2026 to 2036.

April 28, 2026

Eisenmenger Complex Management Market is segmented by Drug Type (Endothelin Receptor Antagonist, Antiarrhythmic Agents, Blood Thinning Agents), Diagnosis (Echocardiogram, Blood tests, Electrocardiogram, Chest X-ray, CT Scan, MRI, Cardiac Catheterization), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

April 28, 2026

Babesiosis Treatment Market is segmented by Drug Type (Generic, Branded), Route of Adminisration (Oral, Injectable, Others), End-Users (Hospitals, Academic Research Institutes, Home Healthcare, Others), and Region. Forecast for 2026 to 2036.

April 28, 2026

Klinefelter Syndrome Therapeutics Market is segmented by Therapeutics (Testosterone Replacement Therapy, Fertility Treatment, Surgeries, Hormone Treatment, Others), Application (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Others), and Region. Forecast for 2026 to 2036.

April 28, 2026

Keratitis Treatment Market is segmented by Keratitis Types (Infectious Keratitis, Noninfectious Keratitis), Treatment (Topical Antibiotics, Antifungals, Antiviral, Biocides), End Users (Hospitals, Specialty Clinics), and Region. Forecast for 2026 to 2036.

April 28, 2026

Hypoventilation Management Market is segmented by Disease Type (Chronic Obstructive Pulmonary Disease, Obesity Hypoventilation Syndrome (OHS), Central Alveolar Hypoventilation, Neuromuscular Disorders), Treatment Type (Non-Invasive Mechanical Ventilation, Oxygen Therapy, Drug Therapy), End User (Hospitals, Specialty clinics, Home care), and Region. Forecast for 2026 to 2036.

April 28, 2026

Hyperpigmentation Treatment Market is segmented by Treatment (Pharmacological Therapy, Laser Treatment, Chemical Peels and Bleach, Microdermabrasion, Skin Grafting or Plastic Surgery), Application (Drug and Cosmetic Stores, Skin Clinics, Hypermarkets and Supermarkets), Product Category (Topical Agents, Laser Therapy Devices, Chemical Peels Formulations, Phototherapy Systems), and Region. Forecast for 2026 to 2036.

April 28, 2026

Generalized Myasthenia Gravis (GMG) Managements Market is segmented by Drug Types (Monoclonal Antibodies, FcRn Inhibitors, Corticosteroid, Cholinesterase Inhibitors, Pharmacotherapy, Therapeutic Plasma Exchange), End Users (Hospitals, Specialty Clinics, Others), Route Of Administration (Oral, Injectable, Subcutaneous), and Region. Forecast for 2026 to 2036.

April 28, 2026

Dystrophic Epidermolysis Bullosa Management Market is segmented by Disease Type (Recessive Dystrophic Epidermolysis Bullosa (RDEB), Dominant Dystrophic Epidermolysis Bullosa (DDEB)), Drug Class (Antibiotics, Corticosteroids, Opioid Analgesics, Anticonvulsant), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region. Forecast for 2026 to 2036.

April 27, 2026

Drug-Induced Immune Hemolytic Anemia Market is segmented by Product (Drug Induced Immune Hemolytic Anemia Treatment, Drug Induced Immune Hemolytic Anemia Diagnostics), Application (Hospital Based Management, Outpatient Management), End Use (Hospitals, Diagnostic Laboratories, Research Institutes), and Region. Forecast for 2026 to 2036.

April 27, 2026

Cannabis Use Disorder Treatment Market is segmented by Type (Marijuana, Tobacco/Nicotine and Vaping, Alcohol, Synthetic Cannabinoids, Others), Treatment (Counselling & Behavioral Therapy, Detoxification, Medication, Support Group), End User (Rehabilitation Centers, Hospitals and Clinics, Others), and Region. Forecast for 2026 to 2036.

April 27, 2026

Frontotemporal Dementia (FTD) Management Market is segmented by Drug Class Type (Antidepressants, Antipsychotics), End-Users (Hospitals, Specialty clinics, Others), Distribution Channel (Hospital Pharmacy, Drug store, Retail Pharmacy, Online Pharmacy, Others), and Region. Forecast for 2026 to 2036.

April 27, 2026

Exophthalmos Treatment Market is segmented by Treatment (Non-surgical Treatment, Surgical Treatment), End User (Specialty Clinics, Hospital Pharmacies, Others), Application (Hospital Pharmacies, Specialty Clinics, Ambulatory Surgical Centers, Other Applications), and Region. Forecast for 2026 to 2036.

April 27, 2026

Encephalitis Treatment Market is segmented by Treatment (Antiviral Agents, Steroid Injection, Antibiotics, Immunoglobulin Therapy, Plasmapheresis, Others), End-Users (Hospitals, Clinic, Others), Diagnosis Method (Imaging Tests, Blood Tests, Biopsy, Other Diagnostic Methods), and Region. Forecast for 2026 to 2036.

April 27, 2026

The Allergy Immunotherapy Market is segmented by Product Type (SLIT tablets, oral, injections, and other product type), Immunotherapy Type (sublingual immunotherapy (SLIT), subcutaneous immunotherapy (allergy shots), and intralymphatic immunotherapy (ILIT)), Indication (allergic rhinitis, allergic asthma, food allergy, atopic dermatitis, and other indication), Allergen Type (pollens, house dust mites (HDM), mould, animal dander, bee venom, cockroaches & insects, and other allergen type), Distribution channel (institutional sales and retail sales), and Region. Forecast for 2026 to 2036.

April 24, 2026

The Actinic Keratosis Treatment Market is segmented by Treatment (antimetabolite chemotherapy agents, NSAID-based anti-proliferative agents, immune response modifiers, microtubule inhibitors, photodynamic therapy, and device-based treatments), Type (lesion-directed AK, field-directed AK, and graded clinical severity), Therapy Route (topical creams, solutions, light-activated agents, and procedure-based), Sales Channel (hospital-based dermatology settings, dermatology clinics, aesthetic & laser clinics, retail pharmacy chains, and online sales channel), and Region. Forecast for 2026 to 2036.

April 24, 2026

Nasal Polyposis Treatment Market is segmented by Type of Treatment (Pharmacological Therapies, Surgeries), Route Of Administration (Nasal, Oral, Injectable), Technology (Conventional Therapies, Advanced Biologic Therapies), and Region. Forecast for 2026 to 2036.

April 23, 2026

Liver Fibrosis Treatment Market is segmented by Treatment Type (Peroxisome Proliferator-activated Receptors Alpha Agonist, ACE Inhibitors, Hepatotropic Drug, Other), Condition (Chronic Liver Diseases, Hepatitis C, Nonalcoholic Steatohepatitis), Disease Indication (Non-Alcoholic Steatohepatitis, Hepatitis B and C Fibrosis, Alcohol-Related Liver Disease, Autoimmune Liver Disease, Genetic Liver Disorders, Others), and Region. Forecast for 2026 to 2036.

April 23, 2026

Next Generation Immunotherapies Market is segmented by Drug Class (Monoclonal Antibodies, Antibody Drug Conjugates, Immune Checkpoint Inhibitors, Ace Inhibitors), Route of Administration (Intravenous, Parenteral, Intratumoral, Subcutaneous, Oral), Technology (Cell Therapy Platforms, Antibody Engineering Platforms, Gene Modified Immunotherapies), and Region. Forecast for 2026 to 2036.

April 22, 2026

Monkeypox Treatment Market is segmented by Treatment Type (Therapeutic, Prophylactic Vaccines), Administration (Oral, Injectable), Technology (Pharmaceutical Therapy, Biotechnology-Based Therapy, Genetic Engineering-Based Therapy), and Region. Forecast for 2026 to 2036.

April 22, 2026

Pleural Diseases Therapeutics Market is segmented by Treatment (Chemotherapy, Drug Class, Bullectomy, Video-Assisted Thoracoscopic Surgery, PleurX Catheter, Pleurodesis Therapy, Radiation Therapy, Thoracentesis, Thoracostomy), Route Of Administration (Injectable, Oral, Intrapleural), Technology (Conventional Therapies, Targeted Therapies), and Region. Forecast for 2026 to 2036.

April 22, 2026

Hospital-Acquired Infection (HAI) Control Market is segmented by Component (Consumables, Equipment, Services), Infection Control Practice (Hand Hygiene Management, Surface Disinfection, Instrument Sterilization, Personal Protective Equipment Usage, Environmental Monitoring), Technology (Sterilization Technology, Disinfection Technology), and Region. Forecast for 2026 to 2036.

April 22, 2026

Leukocyte Adhesion Deficiency Management Market is segmented by Treatment (Hematopoietic Stem Cell Transplantation, Recombinant Human Interferon-gamma Treatment, Prophylactic Immunoglobulin Therapy, Antimicrobial Therapy, Prophylactic Therapy, Fucose Supplementation, Monoclonal Antibodies, Coagulation Factors), Diagnosis (Blood Test, Genetic Testing), Therapy Approach (Curative Therapy, Supportive Therapy, Preventive Therapy), and Region. Forecast for 2026 to 2036.

April 21, 2026

Mucinoses Management Market is segmented by Drug Class (Topical Corticosteroids, Corticosteroid Injections, Oral Antibiotics), Route of Administration (Corticosteroids, Immunosuppressants, Antimalarial Therapies, Retinoids, Biologic Therapies, Combination Therapies, Supportive Symptomatic Care), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), and Region. Forecast for 2026 to 2036.

April 21, 2026

The Absorbable PGA Surgical Sutures Market is segmented by Type (Monofilament 67, Braided, Coated, Non-coated), Application (General Surgery 45, Obstetrics and Gynecology, Urology, Cardiovascular Surgery, Orthopedic Surgery, Others), and Region. Forecast for 2026 to 2036.

April 18, 2026